je.st

Home › fda

Tag: fda

Website highlights FDA policies updating standards for antibiotics used in food animals

2016-09-16 19:09:00| National Hog Farmer

Source: Animal Health Institute Expanded Veterinary Feed Directives go into effect Jan. 1, and producers and veterinarians have yet another place to turn for more information on the changes they face. read more

Tags: website food policies standards

FDA Comes Down On Antibacterial Soap

2016-09-09 20:07:00| Chemical Processing

Government bans chemicals used in antibacterial soap and says there is no evidence they work better than soap and water.

Tags: soap fda antibacterial

More Warning Letters from FDA

2016-09-08 22:00:00| Happi Breaking News

Claims get three new firms in hot water with the agency.

Tags: warning letters fda warning letters

FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants Breakthrough Therapy Designation to Mercks KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2016-09-07 12:45:00| Merck.com - Product News

Dateline City: KENILWORTH, N.J. Merck Has Also Submitted a Marketing Authorization Application to the European Medicines Agency for KEYTRUDA in the Same Patient Population Submissions Based on Data from KEYNOTE-024 Trial Showing Superior Progression-Free and Overall Survival Compared to Chemotherapy in Patients Whose Tumors Express High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors express PD-L1, with a PDUFA, or target action, date of Dec. 24, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: advanced review application license